Growth hormone and ACTH secretory dynamics in Turner's syndrome.
The secretory dynamics of GH and ACTH were studied in 14 patients with Turner's syndrome. The parameters investigated were plasma GH and cortisol responses to hypoglycemia, plasma cortisol circadian rhythm and suppressibility by dexamethasone, and response of urinary Porter-Silber chromogens to metyrapone. The results were mostly normal. These data do not support the hypothesis suggesting an abnormality of hypothalamic-pituitary function in Turner's syndrome.
Reschini
E
E
Service of Nuclear Medicine, Ospedale Maggiore di Milano, Italy.
D'Alberton
A
A
Catania
A
A
Motta
T
T
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000328:Adult; D002648:Child; D002940:Circadian Rhythm; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis; D005838:Genotype; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000378:metabolism; D007986:Luteinizing Hormone / Q000032:analysis; D008797:Metyrapone / Q000494:pharmacology; D014424:Turner Syndrome / Q000378:metabolism*
D015065:17-Hydroxycorticosteroids; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone; D008797:Metyrapone